Free press releases distribution network?

Articles Found

Page: 1 2 3 4 5 6 7 8 9 10 ... Next »



 Recent Articles  Industry   Published  New Window
Ipsen and BioLabs to Open New Innovation Center in Cambridge (U.S.) to Foster Development of New Therapies for Patients Pharma/BioTech/Nutrition 07/19/2018 More
Kiara Health's Vision to Transform Healthcare across Sub-Saharan Africa Applauded by Frost & Sullivan Pharma/BioTech/Nutrition 07/10/2018 More
GenScript to Launch New Platform to Save up to A Billion USD for Worldwide Research Community Pharma/BioTech/Nutrition 07/09/2018 More
Ipsen Announces New Clinical Data to be Presented At ISPRM 2018 Demonstrating Commitment to Neurotoxin Research Pharma/BioTech/Nutrition 07/06/2018 More
Sartorius Signs The United Nations Global Compact Pharma/BioTech/Nutrition 07/03/2018 More
PERT Consortium and BTG Form Strategic Partnership Pharma/BioTech/Nutrition 06/21/2018 More
Greenphire Partners with Lyft to Support Clinical Trial Patient Retention and Access Pharma/BioTech/Nutrition 06/19/2018 More
International Vitamin Corporation Expanding Operations in Greenville County, South Carolina Pharma/BioTech/Nutrition 06/18/2018 More
FDA Approves Genentech’s Avastin (Bevacizumab) Plus Chemotherapy as a Treatment for Women with Advanced Ovarian Cancer Following Initial Surgery Pharma/BioTech/Nutrition 06/13/2018 More
Greenphire Expands Flexibility of eClinicalGPS to Increase CRO and Sponsor Control Pharma/BioTech/Nutrition 06/13/2018 More
Sartorius Stedim Biotech and Siemens Sign Long-term Cooperation Agreement in the Area of Automation Pharma/BioTech/Nutrition 06/12/2018 More
FDA Approves Genentech’s Rituxan (Rituximab) for Pemphigus Vulgaris Pharma/BioTech/Nutrition 06/07/2018 More
Legend Announces FDA Clearance of IND Application on CAR-T Immuno-cell Therapy for the Treatment of Multiple Myeloma Pharma/BioTech/Nutrition 05/30/2018 More
Ipsen and MD Anderson Announce Bench-to-Bedside Cancer Drug Development Partnership Pharma/BioTech/Nutrition 05/29/2018 More
European Commission Approves Ipsen’s Cabometyx® for the First-line Treatment of Adults with Intermediate or Poor Risk Advanced Renal Cell Carcinoma Pharma/BioTech/Nutrition 05/17/2018 More



Page: 1 2 3 4 5 6 7 8 9 10 ... Next »

Reserve This Permanent SPACE

Your LOGO permanently HERE on PRTODAY - Newswire Distribution Service most visited Page start at $295 per month

 
Sponsored Links


Visit Reverie Language Technologies (P) Ltd

Visit  Limelon Advertising, Co.

Visit  BizJobs.com





Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



 
  ©2014 PRTODAY — Limelon Advertising, Co.
Home | About PRTODAY | Advertise | Contact | Investors | Sitemap | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report news market search pr firms pr agencies business reports newswire today distri- bution investor relation successful internet entrepreneur free newswire distribution prtoday freenewswiredistribution.com asianewstoday bizwiretoday newswire pr today
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)